Zuhal KARAKURT, Nezihe ÇİFTASLAN GÖKŞENOĞLU, Nalan ADIGÜZEL, Özlem YAZICIOĞLU MOÇİN, Ethem YILDIZ, Feyza KARGIN, İlim IRMAK

Yoğun bakım ve palyatif bakım ünitelerinin sağkalım oranlarının karşılaştırılmas

Giriş: Palyatif bakım, hastaların ve ailelerin fiziksel, sosyal, psikolojik, kültürel ve manevi desteği ile oluşturulan multidisipliner bir tedavi yaklaşımıdır. Bu çalışmanın amacı, yoğun bakım ünitesi (YBÜ) ve palyatif bakım ünitesinin (PBÜ) sağkalım oranlarını karşılaştırmaktır. Materyal ve Metod: Çalışma retrospektif gözlemsel kohort şeklinde yoğun bakım ünitesinin veri tabanı kullanılarak yapıldı. Yoğun bakım ünitesi veya palyatif bakım ünitesine başvuran terminal hastalığı olan hastalar çalışmaya dahil edildi. Hastaların demografik verileri, komorbiditeleri, yatış, taburculuk ve ölüm tarihleri kaydedildi. Yaşam süresi tahmini ise Kaplan Meier sağkalım analizi kullanılarak yapıldı. Bulgular: Toplamda 112 hasta çalışmaya dahil edildi. Hastaların 60’ı (%53.6) YBÜ grubu ve 52 hasta (%46.4) PBÜ grubu olmak üzere iki gruba ayrıldı. Kaplan-Meier sağkalım tahmin analizi toplam medyan sürenin 29 gün olduğunu göstermiştir. Bu sonuç hastaların %50’sinin YBÜ grubu ve PBÜ grubu için sırasıyla 12 ve 38 gün olduğu, hastaların yarısının 29 günden daha uzun süre hayatta kaldığını göstermiştir (?2= 3.475, p= 0.062). Yoğun bakım ve palyatif bakım ünitelerinin maliyetleri arasında bir fark saptanmadı (p= 0.902). Sonuç: Çalışma uzun dönem sağkalım oranlarının yoğun bakım ve palyatif bakım ünitelerinde benzer olduğunu göstermiştir.

The comparison of the survival rates of intensive and palliative care units

The comparison of the survival rates of intensive and palliative care units Introduction: Palliative care is a multidisciplinary therapy formed by physical, social, psychological, cultural and spiritual support of patients and families. The aim of the present study is to compare the survival rates of the intensive care unit (ICU) and palliative care unit (PCU). Materials and Methods: A retrospective observational cohort study was performed using the database of an intensive care unit. Patients with terminal illness admitted to the intensive care unit or palliative care unit were included in the study. Demographic data, comorbidities, time of admission, discharge and death were recorded. The survival estimation was completed using Kaplan Meier survival analysis. Results: A total of 112 patients were included in the study. Patients were divided into two groups where 60 patients (53.6%) were in Group ICU and 52 (46.4%) were in Group PCU. The Kaplan-Meier estimation of survival curves showed that the overall median time was 29 days. This result demonstrated that 50% of the patients was survived longer than 29 days, in which it was 12 days and 38 days for Group ICU and Group PCU, respectively (?2= 3.475, p= 0.062). The cost of either intensive care unit or palliative care unit did not show any difference (p= 0.902). Conclusion: The present study showed that long-term survival rates are similar in intensive care unit and palliative care unit.

PDF

___

1. http://goldcopd.org/global-strategy-diagnosis-management- prevention-copd-2016/
2. Donaldson GC, Müllerova H, Locantore N, Hurst JR, Calverley PM, Vestbo J, et al. Factors associated with change in exacerbation frequency in COPD. Respir Res 2013; 14: 79.
3. Qureshi H, Sharafkhaneh A, Hanania NA. Chronic obstructive pulmonary disease exacerbations: latest evidence and clinical implications. Ther Adv Chronic Dis 2014; 5(5): 212-27.
4. Khiroya H, Turner AM. The role of iron in pulmonary pathology. Multidiscip Respir Med 2015; 10: 34.
5. DeMeo DL, Mariani T, Bhattacharya S, Srisuma S, Lange C, Litonjua A, et al. Integration of genomic and genetic approaches implicates IREB2 as a COPD susceptibility gene. Am J Hum Genet 2009; 85(4): 493-502.
6. Philippot Q, Deslée G, Adair-Kirk TL, Woods JC, Byers D, Conradi S, et al. Increased iron sequestration in alveolar macrophages in chronic obstructive pulmonary disease. PLoS One 2014; 9(5): e96285.
7. Pniewska E, Sokolowska M, Kupryś-Lipińska I, Kacprzak D, Kuna P, Pawliczak R. Exacerbating factors induce different gene expression profiles in peripheral blood mononuclear cells from asthmatics, patients with chronic obstructive pulmonary disease and healthy subjects
8. Yorgancıoğlu A, Polatlı M, Aydemir Ö, Yılmaz Demirci N, Kırkıl G, Naycı Atış S, et al. Reliability and validity of Turkish version of COPD assessment test. Tuberk Toraks 2012; 60(4): 314-20.
9. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al. Standardisation of spirometry. Eur Respir J 2005; 26(2): 319-38.
10. O’Brien-Ladner AR, Nelson SR, Murphy WJ, Blumer BM, Wesselius LJ. Iron is aregulatory component of human IL-1beta production. Support for regional variability in the lung. Am J Respir Cell Mol Biol 2000; 23(1): 112-9.
11. Ghio AJ, Hilborn ED, Stonehuerner JG, Dailey LA, Carter JD, Richards JH, et al. Particulate matter in cigarette smoke alters iron homeostasis to produce a biological effect. Am J Respir Crit Care Med 2008; 178(11): 1130-8.
12. Siedlinski M, Tingley D, Lipman PJ, Cho MH, Litonjua AA, Sparrow D, et al. COPDGene and ECLIPSE Investigators. Dissecting direct and indirect genetic effects on chronic obstructive pulmonary disease (COPD) susceptibility. Hum Genet 2013; 132(4): 431-41.
13. Chappell SL, Daly L, Lotya J, A lsaegh A, Guetta-Baranes T, Roca J, et al. The role of IREB2 and transforming growth factor beta-1 genetic variants in COPD: a replication casecontrol study. BMC Med Genet 2011; 12: 24.
14. Castaldi PJ, Cho MH, San José Estépar R, McDonald ML, Laird N, Beaty TH, et al. Genome-wide association identifies regulatory Loci associated with distinct local histogram emphysema patterns. Am J Respir Crit Care Med 2014; 190(4): 399-409.
15. Buhnik-Rosenblau K, Moshe-Belizowski S, Danin-Poleg Y, Meyron-Holtz EG. Genetic modification of iron metabolism in mice affects the gut microbiota. Biometals 2012; 25(5): 883-92.
16. Malhotra R, Olsson H. Immunology, genetics and microbiota in the COPD pathophysiology: potential scope for patient stratification. Expert Rev Respir Med 2015; 9(2): 153-9.
17. Lutz SM, Cho MH, Young K, Hersh CP, Castaldi PJ, McDonald M, et al. A genome-wide association study identifies risk loci for spirometric measures among smokers of European and African ancestry. BMC Genet 2015; 16: 138.